Rebound, page-8

They are pounding the pavements in Pitt and Collins because they are trying to find new blood for their next CR. I think the funds will work this out pretty quickly irrespective of whatever blue sky they present. No decent income for the next 6 months with a whole bunch of previous commitments and new commitments ie new R&D. A skinless Board and Management hoping the blue sky will come true one day through their free options whilst they collect their fees and salaries. Shareholders pay for the BB transition from L plate to P plate. A long way to go before the skills are there to manage a research and development medical device company. This ain't a sales and marketing company yet. Long way to go. They just can't admit it all in one go.

Fool me once shame on you, fool me twice shame on me.